JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6676
BK Technologies
BKTI
$286M
| $88 | ﹤0.01% |
6
+1
| +20% | +$12 |
2023 Q3
2 quarters
|
|
|
STRR
6677
Star Equity Holdings
STRR
$36M
| $88 | ﹤0.01% |
5
+2
| +67% | +$31 |
2023 Q3
2 quarters
|
|
6678
Protara Therapeutics
TARA
$160M
| $88 | ﹤0.01% |
22
+6
| +38% | +$19 |
2023 Q3
2 quarters
|
|
6679
Grove Collaborative
GROV
$44.4M
| $87 | ﹤0.01% |
52
+15
| +41% | +$28 |
2023 Q3
2 quarters
|
|
|
USBC
6680
USBC Inc
USBC
$207M
| $87 | ﹤0.01% |
3
| – | – |
2023 Q3
2 quarters
|
|
6681
Flotek Industries
FTK
$1.12B
| $86 | ﹤0.01% |
23
| – | – |
2015 Q4
33 quarters
|
|
6682
KULR Technology Group
KULR
$123M
| $86 | ﹤0.01% |
28
+6
| +27% | +$9 |
2023 Q4
1 quarter
|
|
6683
Smith Micro Software
SMSI
$14.8M
| $86 | ﹤0.01% |
6
-15
| -71% | -$379 |
2020 Q2
15 quarters
|
|
|
CODX
6684
Co-Diagnostics
CODX
$7.54M
| $85 | ﹤0.01% |
3
| – | – |
2020 Q2
15 quarters
|
|
|
XNET
6685
Xunlei
XNET
$300M
| $85 | ﹤0.01% |
57
-72
| -56% | -$108 |
2020 Q1
16 quarters
|
|
|
STCN
6686
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $85 | ﹤0.01% |
9
-13
| -59% | -$119 |
2021 Q2
11 quarters
|
|
6687
Celularity
CELU
$51.9M
| $84 | ﹤0.01% |
16
| – | – |
2022 Q2
7 quarters
|
|
6688
MAIA Biotechnology
MAIA
$73.5M
| $84 | ﹤0.01% |
38
-40
| -51% | -$60 |
2023 Q3
2 quarters
|
|
6689
VistaGen Therapeutics
VTGN
$12.5M
| $84 | ﹤0.01% |
16
| – | – |
2021 Q2
11 quarters
|
|
|
DLA
6690
DELISTED
Delta Apparel Inc.
DLA
| $84 | ﹤0.01% |
28
-828
| -97% | -$4.22K |
2017 Q4
25 quarters
|
|
|
KORE
6691
DELISTED
KORE Group Holdings
KORE
| $83 | ﹤0.01% |
21
+1
| +5% | +$4 |
2023 Q3
2 quarters
|
|
|
TRVN
6692
DELISTED
Trevena, Inc.
TRVN
| $83 | ﹤0.01% |
7
-9
| -56% | -$136 |
2022 Q3
6 quarters
|
|
|
MTEM
6693
DELISTED
Molecular Templates, Inc.
MTEM
| $83 | ﹤0.01% |
37
| – | – |
2017 Q3
26 quarters
|
|
6694
Cryo-Cell International
CCEL
$32.2M
| $82 | ﹤0.01% |
11
+2
| +22% | +$11 |
2023 Q3
2 quarters
|
|
6695
BuzzFeed
BZFD
$97.3M
| $81 | ﹤0.01% |
44
+11
| +33% | +$12 |
2023 Q3
2 quarters
|
|
6696
Great Elm Group
GEG
$64.2M
| $81 | ﹤0.01% |
42
+15
| +56% | +$29 |
2023 Q3
2 quarters
|
|
6697
IN8bio
INAB
$13.8M
| $81 | ﹤0.01% |
2
+1
| +100% | +$38 |
2023 Q3
2 quarters
|
|
6698
Kingstone Companies
KINS
$268M
| $80 | ﹤0.01% |
18
+6
| +50% | +$19 |
2023 Q3
2 quarters
|
|
6699
Bogota Financial
BSBK
$116M
| $78 | ﹤0.01% |
11
-67
| -86% | -$524 |
2023 Q3
2 quarters
|
|
6700
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.36B
| $78 | ﹤0.01% |
1
-65
| -98% | -$3.46K |
2023 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.